Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Seeks To Capitalize On Pliva Infrastructure, Faces Obstacles To Benefits

Executive Summary

Barr is moving ahead with its integration of Pliva, but the firm must overcome several obstacles before it can capitalize on its recently acquired European infrastructure

You may also be interested in...



Barr Cuts Low-Volume Products In Post-Merger Rationalization

Barr is paring low-volume products from its portfolio and pipeline following the integration of Pliva's products and R&D programs

Barr Cuts Low-Volume Products In Post-Merger Rationalization

Barr is paring low-volume products from its portfolio and pipeline following the integration of Pliva's products and R&D programs

Generic Drug Service, Not Pricing, Is Key Performance Factor – Lehman’s Silver

The success of generic companies will be determined more by the breadth and quality of their offerings than product pricing, Lehman Brothers Senior VP-Specialty Pharmaceutical Research Rich Silver told the Generic Pharmaceutical Association

Related Content

UsernamePublicRestriction

Register

LL1135489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel